Debora Beldì
YOU?
Author Swipe
View article: Quality of life in low-risk prostate cancer under active surveillance or following radical treatments: the START cohort study
Quality of life in low-risk prostate cancer under active surveillance or following radical treatments: the START cohort study Open
Compared to radical prostatectomy, AS preserved urinary continence and sexual function but was associated with persistent obstructive symptoms, without differences in general QoL or mental health. This real-world study supports existing ev…
View article: Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer
Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer Open
Importance Although active surveillance for patients with low-risk prostate cancer (LRPC) has been recommended for years, its adoption at the population level is often limited. Objective To make active surveillance available for patients w…
View article: IROCA-TES: Improving Quality in Radiation Oncology through Clinical Audits — Training and Education for Standardization
IROCA-TES: Improving Quality in Radiation Oncology through Clinical Audits — Training and Education for Standardization Open
BACKGROUND: Clinical audits are an important tool to objectively assess clinical protocols, procedures, and processes and to detect deviations from good clinical practice. The main aim of this project is to determine adherence to a core se…
View article: Stereotactic ablative radiotherapy for oligometastatic prostate cancer
Stereotactic ablative radiotherapy for oligometastatic prostate cancer Open
SBRT for oligometastatic prostate cancer offers a good biochemical/local control and tangible delay of hormone/systemic therapy without major toxicities.
View article: Urinary toxicity in patients treated with radical EBRT for prostate cancer: Analysis of predictive factors in an historical series
Urinary toxicity in patients treated with radical EBRT for prostate cancer: Analysis of predictive factors in an historical series Open
Significant independent predictors for acute urinary toxicity grade≥2 were bladder filling, IPSS value, nocturia, and urinary incontinence at baseline assessment.
View article: Long-term outcomes of intraoperative radiation therapy during radical prostatectomy for high-risk prostate cancer
Long-term outcomes of intraoperative radiation therapy during radical prostatectomy for high-risk prostate cancer Open
View article: Radiotherapy in COVID-19 patient affected by multiple myeloma: a case report
Radiotherapy in COVID-19 patient affected by multiple myeloma: a case report Open
In COVID-19 pandemic, cancer patients may be vulnerable for their immunological status and need of immunosuppressive anti-neoplastic treatments. Choosing the best treatment option in COVID-19 positive cancer patients is still a challenging…
View article: Adaptive Strategy for External Beam Radiotherapy in Prostate Cancer and Management of the Geometrical Uncertainties with Robust Optimization
Adaptive Strategy for External Beam Radiotherapy in Prostate Cancer and Management of the Geometrical Uncertainties with Robust Optimization Open
View article: EP-1545 Prostate cancer EBRT: adaptive strategy and use of robust optimization for geometrical uncertainties
EP-1545 Prostate cancer EBRT: adaptive strategy and use of robust optimization for geometrical uncertainties Open
View article: EP-1563: An offline adaptive strategy for external beam radiotherapy in prostate cancer
EP-1563: An offline adaptive strategy for external beam radiotherapy in prostate cancer Open
View article: Three-dimensional surface and ultrasound imaging for daily IGRT of prostate cancer
Three-dimensional surface and ultrasound imaging for daily IGRT of prostate cancer Open
From our data, it emerges that setup misalignments measured by surface imaging can be predictive of US displacements after the adjustment for systematic errors. Moreover, surface imaging can detect setup errors predictive of registration e…
View article: Prostate cancer and androgen deprivation therapy: Metabolic, cardiovascular and psychological side effects
Prostate cancer and androgen deprivation therapy: Metabolic, cardiovascular and psychological side effects Open
Exposure to androgen deprivation therapy (ADT) by prostate cancer (PCa) patients is increasing, either in early-stage and in metastatic disease. Frequently, ADT becomes a long-term treatment, lasting even more than 10 years, starting with …